¹²⁴I-evuzamitide PET/CT Shows Promise for Diagnosing Cardiac Amyloidosis: JAMA

USA: A new clinical trial has found that 124I-evuzamitide positron emission tomography/computed tomography (PET/CT) can accurately detect cardiac amyloidosis, demonstrating 94% sensitivity and 86%...
Read the full report on Business Medical Dialogues
Story file
- Section
- Health
- First reported by
- Business Medical Dialogues
- Reporter
- medha baranwal
- Published
- Wednesday, 14 October 2026, 6:00 am IST
- Coverage
- One outlet so far
How this page works. The Headline Update lists this report from Business Medical Dialogues with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.

